GLA
ALNY icon

Great Lakes Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Great Lakes Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,299
Closed -$316K – 833
2024
Q2 		$316K Buy
+1,299
New +$205K ﹤0.01% 722
2024
Q1 		– Sell
-1,406
Closed -$269K – 806
2023
Q4 		$269K Sell
1,406
-39
-3% -$6.64K ﹤0.01% 692
2023
Q3 		$256K Sell
1,445
-73
-5% -$13.9K ﹤0.01% 682
2023
Q2 		$288K Buy
+1,518
New +$301K ﹤0.01% 649
2021
Q2 		– Sell
-6,565
Closed -$927K – 706
2021
Q1 		$927K Buy
6,565
+256
+4% +$38.5K 0.02% 454
2020
Q4 		$820K Buy
6,309
+1
+0% +$134 0.01% 441
2020
Q3 		$918K Sell
6,308
-1,462
-19% -$208K 0.02% 411
2020
Q2 		$1.15M Sell
7,770
-84
-1% -$11.3K 0.03% 385
2020
Q1 		$855K Buy
+7,854
New +$907K 0.03% 393
2019
Q4 		– Sell
-150,601
Closed -$12.1M – 558
2019
Q3 		$12.1M Buy
+150,601
New +$11.9M 0.27% 96
2015
Q3 		– Sell
-5,433
Closed -$651K – 527
2015
Q2 		$651K Buy
+5,433
New +$649K 0.02% 394

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Great Lakes Advisors's ALNY Position: Q3 2024 in Review

Great Lakes Advisors sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2024, closing a stake of 1,299 shares — an estimated $316K sold.

Great Lakes Advisors first reported a position in ALNY in Q2 2015 and held it in 11 quarters. The position peaked at $12.1M in Q3 2019. 567 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • Great Lakes Advisors reported no remaining Alnylam Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Great Lakes Advisors sold 1,299 Alnylam Pharmaceuticals shares in Q3 2024, an estimated $316K.
  • Great Lakes Advisors first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 11 quarters.
  • Great Lakes Advisors's Alnylam Pharmaceuticals position peaked at $12.1M in Q3 2019.
  • 567 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on Great Lakes Advisors's 13F filing for Q3 2024, filed 4 Nov 2024.